Apelin receptor agonist for the treatment of post-operative cognitive dysfunction

The present invention relates to methods and pharmaceutical compositions for the treatment of post-operative cognitive dysfunction. In particular, the present invention relates to a method of treating post-operative cognitive dysfunction in a subject in need thereof comprising administering to the subject a therapeutically effective amount of an APJ receptor agonist.

Keywords: Neurology - Cognitive dysfunction - Apelin receptor agonist - peptide
Patent Application number: European Procedure (Patents) (EPA) - 15 Févr. 2016 - 16 305 170.9
Inventors:
FRANCES Bernard,VINEL Claire,DRAY Cédric,LABASTE François,MINVILLE Vincent

Reference:

BIO15529-T1

Business Developper
contact
Anne COCHI
Business Development Manager
Patent filling date: 15-02-2016
Rare disease: No
Second indication: No

You might also be interested in